KUMAR AMIT — SEC insider filings
SEC reporting owner CIK 1191905. 35 insider filings on record with FilingPulse; latest filed 2026-11-02.
Transaction summary — filings shown
Covers all 35 filings on record, filed 2020-09-11 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 25 legs across 25 filings — 273,188 shares, $784,414 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 11,800 shares, $42,126 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: purchase of 30,000 shares @ $3.22 ($96,600) in Anixa Biosciences Inc, filed 2024-03-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Anixa Biosciences Inc (ANIX) | Chief Executive Officer, Director | 35 | 25 legs · 273,188 sh · $784,414 | 1 leg · 11,800 sh · $42,126 | 18 |
Insider filings — KUMAR AMIT
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-02 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 5,000 @ $3.17 | EDGAR |
| 2026-10-22 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 8,000 @ $2.72 | EDGAR |
| 2026-09-28 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 7,000 @ $2.78 | EDGAR |
| 2026-09-14 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 3,000 @ $2.75 | EDGAR |
| 2026-09-11 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 5,000 @ $2.76 | EDGAR |
| 2026-08-03 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 5,000 @ $3.47 | EDGAR |
| 2026-07-28 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 5,000 @ $3.44 | EDGAR |
| 2026-07-27 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 3,000 @ $3.73 | EDGAR |
| 2026-07-27 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 3,188 @ $3.37 | EDGAR |
| 2026-07-21 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 5,000 @ $3.46 | EDGAR |
| 2026-07-13 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 5,000 @ $3.04 | EDGAR |
| 2026-06-16 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 21,000 @ $2.50 | EDGAR |
| 2026-01-06 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2025-10-31 | 4 | Anixa Biosciences Inc (ANIX) | Option exercise (M): 200,000 @ $2.92 · Tax withholding (F): 169,439 @ $4.06 · Option exercise (M): 200,000 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 5,000 @ $3.16 | EDGAR |
| 2025-07-14 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 5,000 @ $3.15 | EDGAR |
| 2025-06-05 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 10,000 @ $2.85 | EDGAR |
| 2025-01-15 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 43,000 @ $2.23 | EDGAR |
| 2025-01-03 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 25,000 @ $2.41 | EDGAR |
| 2024-03-15 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 30,000 @ $3.22 | EDGAR |
| 2024-01-16 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2023-07-31 | 4 | Anixa Biosciences Inc (ANIX) | Option exercise (M): 40,000 @ $2.58 · Tax withholding (F): 28,375 @ $3.63 · Sale (S): 11,800 @ $3.57 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2023-01-04 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2022-09-16 | 4 | Anixa Biosciences Inc (ANIX) | Option exercise (M): 640,000 @ $2.58 · Tax withholding (F): 491,900 @ $4.48 · Option exercise (M): 640,000 (derivative) @ $0 | EDGAR |
| 2022-03-11 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2022-01-07 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 20,000 @ $3 | EDGAR |
| 2021-11-01 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 2,000 @ $4.77 | EDGAR |
| 2021-07-27 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 5,000 @ $4.28 | EDGAR |
| 2021-07-20 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 10,000 @ $3.94 | EDGAR |
| 2021-06-02 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 2,000,000 (derivative) @ $0 · Grant/award (A): 500,000 (derivative) @ $0 · Disposition to issuer (D): 1,500,000 (derivative) @ $0 | EDGAR |
| 2021-03-25 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 5,000 @ $4.86 | EDGAR |
| 2021-02-01 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 10,000 @ $3.73 | EDGAR |
| 2020-12-28 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2020-09-11 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 28,000 @ $2.11 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1191905 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs